How is hepatoadrenal syndrome diagnosed in patients with advanced liver disease (e.g., cirrhosis) presenting with unexplained hypotension, hyponatremia, hyperkalemia, fatigue, or refractory shock?

Diagnosis of Hepatoadrenal Syndrome

Hepatoadrenal syndrome (relative adrenal insufficiency in cirrhosis) is diagnosed using the ACTH stimulation test, with a delta cortisol <9 μg/dL (250 nmol/L) after standard-dose Synacthen or a random total cortisol <10 μg/dL (276 nmol/L) in critically ill cirrhotic patients. 1

Diagnostic Approach

When to Suspect Hepatoadrenal Syndrome

Consider this diagnosis in patients with advanced liver disease presenting with:

• Unexplained hypotension or refractory shock (especially requiring vasopressors)
• Hyponatremia (serum sodium <135 mmol/L)
• Hyperkalemia (particularly in primary adrenal insufficiency)
• Persistent fatigue and anorexia
• Sepsis or septic shock (present in 68.9% of cases) 1
• Hemodynamic instability despite adequate fluid resuscitation 2

The condition affects 41.8% of non-critically ill cirrhotic patients and up to 68.9% of those with sepsis or septic shock 1. Recent data shows 59.5% prevalence in patients with acute decompensation and hyponatremia 3.

Diagnostic Testing Protocol

Primary diagnostic test:

• ACTH stimulation test (Synacthen test) using standard-dose (250 μg) or low-dose (1 μg) cosyntropin 1

Diagnostic criteria (choose one):

1. Delta cortisol approach: Rise in total serum cortisol <9 μg/dL (250 nmol/L) after ACTH administration 1

2. Random cortisol approach: Random total cortisol <10 μg/dL (276 nmol/L) in critically ill patients 1

3. Free cortisol criteria (if available):

   • Baseline serum-free cortisol <50 nmol/L, OR
   • Post-ACTH free cortisol <86 nmol/L (9 μg/dL) 1

4. Salivary cortisol (alternative method):

   • Baseline salivary cortisol <1.8 ng/mL (0.18 μg/dL), OR
   • Increment <3 ng/mL (0.3 μg/dL) after Synacthen test 1

Critical Diagnostic Pitfalls

Major limitation: Standard total cortisol measurements may overestimate adrenal insufficiency in cirrhosis due to:

• Reduced cortisol-binding globulin (CBG) levels
• Hypoalbuminemia (>90% of cortisol is protein-bound) 1

In one study, RAI prevalence was 58% using total cortisol criteria but only 12% using free cortisol 1. This discrepancy is clinically significant—a recent case report demonstrated normal salivary cortisol despite low total cortisol, questioning the actual presence of adrenal insufficiency 4.

Alternative testing when cosyntropin unavailable: Subcutaneous long-acting porcine ACTH is a feasible alternative, showing similar diagnostic accuracy 3.

Workup to Rule Out Other Causes

Before diagnosing hepatoadrenal syndrome, exclude:

1. Infection/sepsis: Diagnostic paracentesis, cultures, procalcitonin 5, 2
2. Volume depletion: Trial of albumin (1 g/kg/day up to 100 g/day for ≥2 days) 6
3. Nephrotoxic medications: Review all drugs 6
4. Structural kidney disease: Urinalysis for proteinuria >500 mg/day, microhematuria, renal ultrasound 6
5. Thyroid dysfunction: TSH, free T4 5
6. Gastrointestinal bleeding: Hemoglobin, stool guaiac 5
7. Shock from other causes: Assess hemodynamics 6

Clinical Context Matters

Do NOT wait for test results in acute situations. If a patient with cirrhosis presents with shock or severe decompensation, start empiric hydrocortisone immediately while awaiting cortisol results 7. However, recognize that empiric steroid therapy carries risks including receptor downregulation and iatrogenic complications 4.

Prognostic Implications

RAI independently predicts 90-day mortality in patients with acute decompensation and hyponatremia (68.1% vs 46.7% in non-RAI patients, p=0.01) 3. This effect is most pronounced in patients with MELD score <25 3.

Baseline cortisol levels correlate with disease severity: higher baseline cortisol (18.8 μg/dL vs 13.0 μg/dL) paradoxically indicates worse prognosis and higher mortality 8. In vasopressor-dependent patients, baseline cortisol of 10.0 μg/dL suggests adrenal insufficiency, while 35.6 μg/dL suggests normal function but severe illness 8.

Practical Recommendation

Use total cortisol testing with clinical correlation since free cortisol and salivary cortisol methods are complex, expensive, and not routinely available 1. However, interpret results cautiously in the context of albumin levels, clinical response to treatment, and hemodynamic parameters rather than relying solely on biochemical thresholds 4.